BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Šterbenc A, Jarc E, Poljak M, Homan M. Helicobacter pylori virulence genes. World J Gastroenterol 2019; 25(33): 4870-4884 [PMID: 31543679 DOI: 10.3748/wjg.v25.i33.4870] [Cited by in CrossRef: 53] [Cited by in F6Publishing: 43] [Article Influence: 17.7] [Reference Citation Analysis]
Number Citing Articles
1 Prada CF, Casadiego MA, Freire CC. Evolution of Helicobacter spp: variability of virulence factors and their relationship to pathogenicity. PeerJ 2022;10:e13120. [DOI: 10.7717/peerj.13120] [Reference Citation Analysis]
2 Salinas Ibáñez ÁG, Origone AL, Liggieri CS, Barberis SE, Vega AE. Asclepain cI, a proteolytic enzyme from Asclepias curassavica L., a south American plant, against Helicobacter pylori. Front Microbiol 2022;13:961958. [DOI: 10.3389/fmicb.2022.961958] [Reference Citation Analysis]
3 Hiengrach P, Panpetch W, Chindamporn A, Leelahavanichkul A. Helicobacter pylori, Protected from Antibiotics and Stresses Inside Candida albicans Vacuoles, Cause Gastritis in Mice. IJMS 2022;23:8568. [DOI: 10.3390/ijms23158568] [Reference Citation Analysis]
4 Wang YK, Zhou JL, Meng NL, Zhu CY, Wang SN, Chen XD. How Does Helicobacter pylori Infection Cause Gastric Mucosal Atrophy. Infect Drug Resist 2022;15:3619-29. [PMID: 35837536 DOI: 10.2147/IDR.S355981] [Reference Citation Analysis]
5 Dai YY, Qin C, Huang GR, Qin YC, Huang YY, Huang YQ, Zhao LJ. Linolenic Acid-Metronidazole: a Compound Relieving Drug Resistance and Inhibiting Helicobacter pylori. Antimicrob Agents Chemother 2022;:e0007322. [PMID: 35758720 DOI: 10.1128/aac.00073-22] [Reference Citation Analysis]
6 He J, Hu W, Ouyang Q, Zhang S, He L, Chen W, Li X, Hu C. Helicobacter pylori infection induces stem cell-like properties in Correa cascade of gastric cancer. Cancer Lett 2022;:215764. [PMID: 35654291 DOI: 10.1016/j.canlet.2022.215764] [Reference Citation Analysis]
7 Vital JS, Tanoeiro L, Lopes-oliveira R, Vale FF. Biomarker Characterization and Prediction of Virulence and Antibiotic Resistance from Helicobacter pylori Next Generation Sequencing Data. Biomolecules 2022;12:691. [DOI: 10.3390/biom12050691] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Wu X, Jian A, Tang H, Liu W, Liu F, Liu S, Wu H. A Multi-Omics Study on the Effect of Helicobacter Pylori-Related Genes in the Tumor Immunity on Stomach Adenocarcinoma. Front Cell Infect Microbiol 2022;12:880636. [DOI: 10.3389/fcimb.2022.880636] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Calado CRC. Antigenic and conserved peptides from diverse Helicobacter pylori antigens. Biotechnol Lett. [DOI: 10.1007/s10529-022-03238-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Han L, Shu X, Wang J. Helicobacter pylori-Mediated Oxidative Stress and Gastric Diseases: A Review. Front Microbiol 2022;13:811258. [PMID: 35211104 DOI: 10.3389/fmicb.2022.811258] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
11 Yan J, Peng C, Chen P, Zhang W, Jiang C, Sang S, Zhu W, Yuan Y, Hong Y, Yao M. In-vitro anti-Helicobacter pylori activity and preliminary mechanism of action of Canarium album Raeusch. fruit extracts. J Ethnopharmacol 2022;283:114578. [PMID: 34464702 DOI: 10.1016/j.jep.2021.114578] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
12 Sonkar C, Varshney N, Koganti S, Jha HC. Kinases and therapeutics in pathogen mediated gastric cancer. Mol Biol Rep 2022. [PMID: 35031925 DOI: 10.1007/s11033-021-07063-9] [Reference Citation Analysis]
13 Peng C, Sang S, Shen X, Zhang W, Yan J, Chen P, Jiang C, Yuan Y, Zhu W, Yao M. In vitro anti-Helicobacter pylori activity of Syzygium aromaticum and the preliminary mechanism of action. J Ethnopharmacol 2022;:114995. [PMID: 35032584 DOI: 10.1016/j.jep.2022.114995] [Reference Citation Analysis]
14 Sonnenberg A. Epidemiology of Helicobacter pylori. Aliment Pharmacol Ther 2022;55 Suppl 1:S1-S13. [PMID: 34989430 DOI: 10.1111/apt.16592] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Salinas Ibáñez ÁG, Vallés D, Adaro M, Barberis S, Vega AE. Antimicrobial Effect of a Proteolytic Enzyme From the Fruits of Solanum granuloso-leprosum (Dunal) Against Helicobacter pylori. Front Nutr 2021;8:699955. [PMID: 34977105 DOI: 10.3389/fnut.2021.699955] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Keikha M, Sahebkar A, Yamaoka Y, Karbalaei M. Helicobacter pylori cagA status and gastric mucosa-associated lymphoid tissue lymphoma: a systematic review and meta-analysis. J Health Popul Nutr 2022;41:2. [PMID: 34980267 DOI: 10.1186/s41043-021-00280-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
17 Rodriguez AM, Urrea DA, Prada CF. Helicobacter pylori virulence factors: relationship between genetic variability and phylogeographic origin. PeerJ 2021;9:e12272. [PMID: 34900406 DOI: 10.7717/peerj.12272] [Reference Citation Analysis]
18 Senchukova MA, Tomchuk O, Shurygina EI. Helicobacter pylori in gastric cancer: Features of infection and their correlations with long-term results of treatment. World J Gastroenterol 2021;27:6290-305. [PMID: 34712033 DOI: 10.3748/wjg.v27.i37.6290] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
19 Valizadeh M, ur Rehman F, Hassanzadeh MA, Beigomi M, Fazeli-nasab B. Investigating the Antimicrobial Effects of Glycyrrhiza glabra and Salvia officinalis Ethanolic Extract Against Helicobacter pylori. Int J Infect 2021;8. [DOI: 10.5812/iji.114563] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
20 Zuo NY, Zhang YD, Dong QW, Bi J, Liu X. Effect of Anti-Hp treatment on nutritional status of children with Helicobacter Pylori-Positive Gastritis and its clinical significance. Pak J Med Sci 2021;37:1430-4. [PMID: 34475925 DOI: 10.12669/pjms.37.5.4234] [Reference Citation Analysis]
21 Askari P, Karbalaei M, Ghazvini K, Keikha M. Severe clinical outcomes of infection with babA2-positive Helicobacter pylori strains in the Iranian population: A systematic review and meta-analysis. Meta Gene 2021;29:100911. [DOI: 10.1016/j.mgene.2021.100911] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
22 Jiang X, Xu Z, Zhang T, Li Y, Li W, Tan H. Whole-Genome-Based Helicobacter pylori Geographic Surveillance: A Visualized and Expandable Webtool. Front Microbiol 2021;12:687259. [PMID: 34408729 DOI: 10.3389/fmicb.2021.687259] [Reference Citation Analysis]
23 Taxauer K, Hamway Y, Ralser A, Dietl A, Mink K, Vieth M, Singer BB, Gerhard M, Mejías-Luque R. Engagement of CEACAM1 by Helicobacterpylori HopQ Is Important for the Activation of Non-Canonical NF-κB in Gastric Epithelial Cells. Microorganisms 2021;9:1748. [PMID: 34442827 DOI: 10.3390/microorganisms9081748] [Reference Citation Analysis]
24 Kim SY, Park JM, Lim CH, Lee HA, Shin GY, Choe Y, Cho YK, Choi MG. Types of 23S Ribosomal RNA Point Mutations and Therapeutic Outcomes for Helicobacter pylori. Gut Liver 2021;15:528-36. [PMID: 33376228 DOI: 10.5009/gnl20225] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
25 Gastli N, Allain M, Lamarque D, Abitbol V, Billoët A, Collobert G, Coriat R, Terris B, Kalach N, Raymond J. Diagnosis of Helicobacter pylori Infection in a Routine Testing Workflow: Effect of Bacterial Load and Virulence Factors. J Clin Med 2021;10:2755. [PMID: 34201588 DOI: 10.3390/jcm10132755] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Jonaitis P, Kupcinskas J, Nyssen OP, Puig I, Gisbert JP, Jonaitis L. Evaluation of the Effectiveness of Helicobacter pylori Eradication Regimens in Lithuania during the Years 2013-2020: Data from the European Registry on Helicobacter pylori Management (Hp-EuReg). Medicina (Kaunas) 2021;57:642. [PMID: 34201428 DOI: 10.3390/medicina57070642] [Reference Citation Analysis]
27 Xue Z, Yang H, Su D, Song X, Deng X, Yu C, Sun C, He L, You Y, Gong Y, Fan D, Sun L, Han X, Fan R, Zhang M, Yan X, Qian J, Zhang J. Geographic distribution of the cagA, vacA, iceA, oipA and dupA genes of Helicobacter pylori strains isolated in China. Gut Pathog 2021;13:39. [PMID: 34130751 DOI: 10.1186/s13099-021-00434-4] [Reference Citation Analysis]
28 Zhang Y, Feng XY, Li GQ, Xu F, Liu F, Li YY, Deng B. Epidemiological study of Helicobacter pylori infection and its relationship with pathologic changes of the antral mucosa in rural areas of Yangzhou. Shijie Huaren Xiaohua Zazhi 2021; 29(10): 550-556 [DOI: 10.11569/wcjd.v29.i10.550] [Reference Citation Analysis]
29 Whiteside SA, Mohiuddin MM, Shlimon S, Chahal J, MacPherson CW, Jass J, Tompkins TA, Creuzenet C. In Vitro Framework to Assess the Anti-Helicobacter pylori Potential of Lactic Acid Bacteria Secretions as Alternatives to Antibiotics. Int J Mol Sci 2021;22:5650. [PMID: 34073352 DOI: 10.3390/ijms22115650] [Reference Citation Analysis]
30 Keikha M, Karbalaei M. Correlation between the geographical origin of Helicobacter pylori homB-positive strains and their clinical outcomes: a systematic review and meta-analysis. BMC Gastroenterol 2021;21:181. [PMID: 33879080 DOI: 10.1186/s12876-021-01764-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
31 Lee DH, Ha JH, Shin JI, Kim KM, Choi JG, Park S, Park JS, Seo JH, Park JS, Shin MK, Baik SC, Lee WK, Youn HS, Cho MJ, Kang HL, Jung M. Increased Risk of Severe Gastric Symptoms by Virulence Factors vacAs1c, alpA, babA2, and hopZ in Helicobacter pylori Infection. J Microbiol Biotechnol 2021;31:368-79. [PMID: 33622995 DOI: 10.4014/jmb.2101.01023] [Reference Citation Analysis]
32 de Souza MPC, de Camargo BAF, Spósito L, Fortunato GC, Carvalho GC, Marena GD, Meneguin AB, Bauab TM, Chorilli M. Highlighting the use of micro and nanoparticles based-drug delivery systems for the treatment of Helicobacter pylori infections. Crit Rev Microbiol 2021;47:435-60. [PMID: 33725462 DOI: 10.1080/1040841X.2021.1895721] [Reference Citation Analysis]
33 Jonaityte IR, Ciupkeviciene E, Jonaitis P, Kupcinskas J, Petkeviciene J, Jonaitis L. Changes in the Seroprevalence of Helicobacter pylori among the Lithuanian Medical Students over the Last 25 Years and Its Relation to Dyspeptic Symptoms. Medicina (Kaunas) 2021;57:254. [PMID: 33803389 DOI: 10.3390/medicina57030254] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Xu X, Chen J, Huang X, Feng S, Zhang X, She F, Wen Y. The Role of a Dipeptide Transporter in the Virulence of Human Pathogen, Helicobacter pylori. Front Microbiol 2021;12:633166. [PMID: 33732225 DOI: 10.3389/fmicb.2021.633166] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Alavifard H, Mirzaei N, Yadegar A, Baghaei K, Smith SM, Sadeghi A, Zali MR. Investigation of Clarithromycin Resistance-Associated Mutations and Virulence Genotypes of Helicobacter pylori Isolated from Iranian Population: A Cross-Sectional Study. Curr Microbiol 2021;78:244-54. [PMID: 33251569 DOI: 10.1007/s00284-020-02295-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Thanaphongdecha P, Karinshak SE, Ittiprasert W, Mann VH, Chamgramol Y, Pairojkul C, Fox JG, Suttiprapa S, Sripa B, Brindley PJ. Infection with Helicobacter pylori Induces Epithelial to Mesenchymal Transition in Human Cholangiocytes. Pathogens 2020;9:E971. [PMID: 33233485 DOI: 10.3390/pathogens9110971] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
37 Fisher L, Fisher A, Smith PN. Helicobacter pylori Related Diseases and Osteoporotic Fractures (Narrative Review). J Clin Med 2020;9:E3253. [PMID: 33053671 DOI: 10.3390/jcm9103253] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
38 Hartl K, Sigal M. Microbe-Driven Genotoxicity in Gastrointestinal Carcinogenesis. Int J Mol Sci 2020;21:E7439. [PMID: 33050171 DOI: 10.3390/ijms21207439] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
39 Nishizawa T, Sakitani K, Suzuki H, Yoshida S, Kataoka Y, Nakai Y, Ebinuma H, Kanai T, Toyoshima O, Koike K. Clinical features of cardiac nodularity-like appearance induced by Helicobacter pylori infection. World J Gastroenterol 2020; 26(35): 5354-5361 [PMID: 32994693 DOI: 10.3748/wjg.v26.i35.5354] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
40 Jarzab M, Posselt G, Meisner-Kober N, Wessler S. Helicobacter pylori-Derived Outer Membrane Vesicles (OMVs): Role in Bacterial Pathogenesis? Microorganisms 2020;8:E1328. [PMID: 32878302 DOI: 10.3390/microorganisms8091328] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
41 Wang LY, Zhao S, Lv GJ, Ma XJ, Zhang JB. Mechanisms of resveratrol in the prevention and treatment of gastrointestinal cancer. World J Clin Cases 2020; 8(12): 2425-2437 [PMID: 32607320 DOI: 10.12998/wjcc.v8.i12.2425] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
42 Krzyżek P, Grande R. Transformation of Helicobacter pylori into Coccoid Forms as a Challenge for Research Determining Activity of Antimicrobial Substances. Pathogens 2020;9:E184. [PMID: 32143312 DOI: 10.3390/pathogens9030184] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
43 Ji J, Yang H. Using Probiotics as Supplementation for Helicobacter pylori Antibiotic Therapy.Int J Mol Sci. 2020;21. [PMID: 32046317 DOI: 10.3390/ijms21031136] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]